AACR VIRTUAL PATIENT ADVOCATE FORUM
HOW EVOLUTION SHAPES CANCER
December 13, 2021
VIRTUALRegister for on demand viewing
Evolutionary theories are shaping how we understand the evolution of cancer and cancer metastasis. Integrating evolutionary theory into cancer treatment is key to recognizing and controlling therapeutic resistance and developing proactive therapy regimens. This Patient Advocate Forum explores ways that cancer evolution can impact and develop new biomarkers and more effective therapeutic targets.
Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine of USC, Los Angeles, CA
Charles Swanton, MD, PhD, FRCP, FAACR, FRS, The Francis Crick Institute & UCL Cancer Institute, London, UK
Jamie Holloway, PhD, Caris Life Sciences, Arlington, VA
Susan M. Rosenberg, PhD, Baylor College of Medicine, Houston, TX
Franziska Michor, PhD, Harvard University, Cambridge, MA
Robert A. Gatenby, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FLProgram Agenda Speaker Bios
AACR Patient Advocate Forums
The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and health care communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.